$QNTA announced that the Company has received a re
Post# of 36914
(Total Views: 79)
Posted On: 06/25/2021 2:18:08 PM
$QNTA announced that the Company has received a response from the U.S. Food and Drug Administration (FDA) relating to its Pre-Investigational New Drug (Pre-IND) filing on its lead drug candidate Escozine® for the treatment of the SARS-CoV-2 (COVID-19) virus. The response validated the Company’s clinical study conducted in the Dominican Republic (DR) and outlined next steps for its approval process in the US.
https://finance.yahoo.com/news/fda-accepts-co...00620.html
https://finance.yahoo.com/news/fda-accepts-co...00620.html
(0)
(0)
Scroll down for more posts ▼